Well the theory is in place for "RescART" (Reservoir cART - cute name I thought - lol). If they have the problem of needing to withdraw BIT225 to see if the mRNA regains detectable levels that will be a major victory.
I'm not sure I understand the full underlying purpose of the treatment naive study. Is there the possibility that being treatment naive could allow reservoir clearance with initial cART? I.e. does cART gradually lose some of its impact over time, meaning the BIT combo could have more oomph? Anybody know?
Ann: $1.43M R&D rebate received, page-54
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $5.671K | 298.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 512798 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1050263 | 5 |
View Market Depth
| Last trade - 15.59pm 04/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |